| Dr Saul Arber, MD | |
|
1100 Grampian Blvd, Williamsport, PA 17701-1907 | |
| (570) 326-8203 | |
| (570) 322-4931 |
| Full Name | Dr Saul Arber |
|---|---|
| Gender | Male |
| Speciality | Radiation Oncology |
| Experience | 39 Years |
| Location | 1100 Grampian Blvd, Williamsport, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1407800949 | NPI | - | NPPES |
| 8722803 | Medicaid | NJ | |
| 02098373 | Medicaid | NY |
| Facility Name | Location | Facility Type |
|---|---|---|
| Hutchinson Regional Medical Center Inc | Hutchinson, KS | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hutchinson Regional Medical Center Inc | 0648181198 | 53 |
News Archive
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, signed an agreement for the purchase of a Renaissance system with Richard R. M. Francis, MD, of Spine Associates of Houston and the Houston Orthopedic and Spine Hospital, formerly known as Foundation Surgical Hospital, in Bellaire, Texas.
A major new initiative by the University of Maryland aims to eliminate health disparities in the state and extend the impact of health reform. The university's School of Public Health has recruited a team of nationally recognized faculty-researchers who will create action programs to improve primary care and expand public health outreach, so as to reduce the high rates of chronic disease in Maryland's medically underserved communities.
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.
Sosei Group Corporation, announced today that it has reached an agreement to acquire 100% of Activus Pharma Ltd., a privately-held biopharmaceutical company based in Chiba, Japan.
A specially designed lipid nanoparticle could deliver immune-signaling molecules into liver macrophage cells to overcome resistance to anti-tumor immunotherapy.
› Verified 4 days ago
| Entity Name | Hutchinson Regional Medical Center Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1972605285 PECOS PAC ID: 0648181198 Enrollment ID: O20040119000578 |
News Archive
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, signed an agreement for the purchase of a Renaissance system with Richard R. M. Francis, MD, of Spine Associates of Houston and the Houston Orthopedic and Spine Hospital, formerly known as Foundation Surgical Hospital, in Bellaire, Texas.
A major new initiative by the University of Maryland aims to eliminate health disparities in the state and extend the impact of health reform. The university's School of Public Health has recruited a team of nationally recognized faculty-researchers who will create action programs to improve primary care and expand public health outreach, so as to reduce the high rates of chronic disease in Maryland's medically underserved communities.
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.
Sosei Group Corporation, announced today that it has reached an agreement to acquire 100% of Activus Pharma Ltd., a privately-held biopharmaceutical company based in Chiba, Japan.
A specially designed lipid nanoparticle could deliver immune-signaling molecules into liver macrophage cells to overcome resistance to anti-tumor immunotherapy.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr Saul Arber, MD 1201 Grampian Blvd, Williamsport, PA 17701-1900 Ph: () - | Dr Saul Arber, MD 1100 Grampian Blvd, Williamsport, PA 17701-1907 Ph: (570) 326-8203 |
News Archive
Mazor Robotics Ltd., the leader in innovative surgical robots and complementary products for spine surgery, signed an agreement for the purchase of a Renaissance system with Richard R. M. Francis, MD, of Spine Associates of Houston and the Houston Orthopedic and Spine Hospital, formerly known as Foundation Surgical Hospital, in Bellaire, Texas.
A major new initiative by the University of Maryland aims to eliminate health disparities in the state and extend the impact of health reform. The university's School of Public Health has recruited a team of nationally recognized faculty-researchers who will create action programs to improve primary care and expand public health outreach, so as to reduce the high rates of chronic disease in Maryland's medically underserved communities.
UCSF researchers have developed a new approach to identify specific genes that influence how cancer cells respond to drugs and how they become resistant. This strategy, which involves producing diverse genetic mutations that result in leukemia and associating specific mutations with treatment outcomes, will enable researchers to better understand how drug resistance occurs in leukemia and other cancers, and has important long-term implications for the development of more effective therapies.
Sosei Group Corporation, announced today that it has reached an agreement to acquire 100% of Activus Pharma Ltd., a privately-held biopharmaceutical company based in Chiba, Japan.
A specially designed lipid nanoparticle could deliver immune-signaling molecules into liver macrophage cells to overcome resistance to anti-tumor immunotherapy.
› Verified 4 days ago
Benjamin Bansun Chang, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 740 High St Ste 2001, Williamsport, PA 17701 Phone: 703-212-8055 | |
David Quintana, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-322-1161 Fax: 570-322-2030 | |
Dr. Richard Douglas Walter, M.D. Radiology Medicare: Not Enrolled in Medicare Practice Location: 87 Selkirk Rd, Williamsport, PA 17701 Phone: 570-326-4828 | |
Abike O. Durojaye, M.D. Radiology Medicare: Accepting Medicare Assignments Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-322-1161 Fax: 570-322-2030 | |
Prakash G Koshy, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-322-1161 Fax: 570-322-2030 | |
Chin-chin Yeh, MD Radiology Medicare: Accepting Medicare Assignments Practice Location: 740 High St Ste 2001, Williamsport, PA 17701 Phone: 570-321-2805 | |
Shabbir Esaa, MD Radiology Medicare: Not Enrolled in Medicare Practice Location: 700 High St, Williamsport, PA 17701 Phone: 570-322-1161 Fax: 570-322-2030 |